EV
Molecule Holdings Inc.
EVRRF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $889.8K
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/S 0.45x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 54.56%
Net margin 230.84%
Op. margin 198.86%
Quality
9 /100
Poor ROIC 250.72%
ROA 116.15%
Asset turnover 0.50x
Debt
50 /100
Moderate Current ratio 0.17x
Int. coverage -6.16x
Net debt/EBITDA -1.57x
Stability
19 /100
Unstable Beta -0.43x
EPS volatility 82.83%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EVRRF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
David Reingold
Employees
13
Headquarters
Lansdowne